Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

  • Read more about The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

CStone Pharmaceuticals (Suzhou) Co., Ltd.

By jpalfreyman on Fri, 06/30/2023 - 09:38
  • Read more about CStone Pharmaceuticals (Suzhou) Co., Ltd.

Mortality, Gravity Predictive Factors and Clinical Evolution of Older COVID-19 Patients in Short Geriatric Services.

  • Read more about Mortality, Gravity Predictive Factors and Clinical Evolution of Older COVID-19 Patients in Short Geriatric Services.

CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19

  • Read more about CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19

A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.

  • Read more about A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.

An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia

  • Read more about An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia

Quantifying Viral Load in Respiratory Particles That Are Generated by Children and Adults With COVID-19 Infection

  • Read more about Quantifying Viral Load in Respiratory Particles That Are Generated by Children and Adults With COVID-19 Infection

Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine

  • Read more about Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine

Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine

  • Read more about Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine

The Effect on Pain and Satisfaction of Two Different Non-Pharmacological Methods Used During Coronavirus (Covid-19) Vaccination

  • Read more about The Effect on Pain and Satisfaction of Two Different Non-Pharmacological Methods Used During Coronavirus (Covid-19) Vaccination

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 121
  • Page 122
  • Page 123
  • Page 124
  • Current page 125
  • Page 126
  • Page 127
  • Page 128
  • Page 129
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA